Previous Close | 40.62 |
Open | 33.60 |
Bid | 32.92 x 100 |
Ask | 33.05 x 300 |
Day's Range | 32.61 - 35.20 |
52 Week Range | 21.38 - 48.81 |
Volume | |
Avg. Volume | 1,297,758 |
Market Cap | 3.576B |
Beta (5Y Monthly) | 1.01 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Novavax stock surged after the vaccine maker signs a $1.2 billion licensing deal with France’s Sanofi, guidance from Akamai Technologies missed estimates, and Sweetgreen soared after the salad chain boosts its full-year revenue outlook.
JFrog Ltd. (NASDAQ:FROG) Q1 2024 Earnings Call Transcript May 9, 2024 JFrog Ltd. misses on earnings expectations. Reported EPS is $-0.08213 EPS, expectations were $0.14. FROG isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, thank you for […]
JFrog shares are down sharply Friday after the provider of software-development tools posted first-quarter results that left investors hungry for more.